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Fanconi anemia (FA) is a rare genetically heterogeneous disease 
characterized by developmental abnormalities, progressive bone marrow failure, 
and cancer susceptibility. We examined spontaneous, diepoxybutane (DEB)-
induced and radiation-induced sister chromatid exchanges (SCEs) in whole-
blood lymphocyte cultures of bone marrow failure (BMF) patients including 
Fanconi anemia, mothers of affected individuals, and healthy controls. The base-
line frequency of SCE in FA cells was similar to that observed in controls. 
However, in response to DEB SCE frequencies in FA patients and their mothers 
were significantly increased compared to both non-FA BMF families and healthy 
controls. In response to ionizing radiation, cells displayed increased frequency of 
SCE, but no differences between FA patients and non-FA BMF patients were 
seen. Our data confirm and expand previous findings by showing that SCE 
induced by DEB can be used as an adjunct diagnostic test not only for FA 
patients, but also for female heterozygous carriers, at least for complementation 
groups FANCA and FANCD2.  
Key words: diepoxybutane, Fanconi anemia lymphocytes, ionizing 
radiation, sister chromatid exchange  
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INTRODUCTION 
The Fanconi anemia (FA) molecular network consists of at least 15 FANC proteins 
identified thus far (HUCL and GALLMEIER, 2011). Studies on their functions revealed their main 
role in protecting against genotoxic stress by forming complexes with each other. However, all 
that proteins also participate in survival signaling pathways in hematopoietic and germ cells, and 
that second function does not necessarily require the nuclear complex formation. At least four 
FANC proteins (FANCA, FANCC, FANCG and FANCD2) have dual roles in distinct cellular 
pathways that respond to replication fork damage and oxidative stress (KONTOU et al., 2003; 
MUKHOPADHYAY et al., 2006; WILLERS et al., 2008). 
FA is characterized by variability of clinical phenotypes (JOENJE and PATEL, 2001; 
YAMASHITA and NAKAHATA, 2001), but the common, historically known feature associated with 
FA mutation is marked chromosomal instability (GRANT  et al., 2005) manifested as chromatid 
breaks and chromatid exchanges (SCHROEDER et al., 1964). About 10 years after the discovery of 
spontaneous chromosomal instability as cytogenetic hallmark of FA, Sasaki and Tonomura 
(SASAKI and TONOMURA, 1973) showed its association with a high rate of induced chromosomal 
aberrations after treatment with DNA cross-linking agents, such as diepoxybutane (DEB) or 
mitomycin C (MMC). As the management of patients with FA differs from that of idiopathic 
bone marrow failure (BMF) syndromes, it is essential to differentiate these disorders at the 
earliest. The determination of cellular sensitivity towards DEB still serves as a gold standard for 
the diagnosis and exclusion of Fanconi anemia. 
During the last decade, several in vitro assays have been developed to facilitate 
diagnosis of FA (LESKOVAC et al., 2010; JOKSIC et al., 2012). It is known that FA heterozygotes 
cannot be detected by the DEB test because their results are within the normal range (AUERBACH, 
2003). Similar to that, Mohseni-Meybodi et al. (MOHSENI-MEYBODI et al., 2007) underlined that 
differentiation between obligate carriers and the control group, based on chromosomal aberration 
analysis after MMC treatment and gamma irradiation is impossible. On the contrary, Barquinero 
et al. (BARQUINERO et al., 2001) reported significantly higher incidence of bleomycin-induced 
chromatid breaks in G2 lymphocytes of FA heterozygotes. Besides metaphase analysis 
(AUERBACH, 2003), sensitivity of FA cells to cross-linking agents or ionizing radiation usually 
was determined using cell cycle examination (SEYSCHAB et al., 1995), comet assay (DJUZENOVA 
and FLENTJE, 2002), etc. 
The sister chromatid exchange (SCE) analysis is used extensively to evaluate the 
presence and extent of chromosomal damage in human populations (TUCKER and PRESTON, 
1996). Moreover, SCE is much more sensitive as a mutagenic biomarker than chromosomal 
aberrations and micronuclei (CINKILIC et al., 2009). Spontaneous SCE frequencies are believed 
to be normal in FA patients, but studies on induced SCE have yielded conflicting results. Some 
studies using DEB found no considerable changes in SCE levels in FA cells (PORFIRIO et al., 
1983; GEBHART et al., 1985), but example of increased level induced by MMC is also noted 
(MIURA et al., 1983). However, it is worth noting that DEB and MMC differ in the mechanisms 
underlying their toxicity (PAGANO and KORKINA, 2000). In addition, most of the studies 
involving sensitivity of FA cells to cross-linking agents were performed without knowing 
patients’ complementary groups. The results of our recent work have shown an in vivo 
prooxidant state of cells in FANCA and FANCD2 patients and clearly indicate that FA patients 
can be distinguished from idiopathic BMF patients based on the oxidant state of cells. Similar 
prooxidant state of cells was noted in female heterozygous carriers, but in none of the male 
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carriers (PETROVIC et al., 2011). Knowing that the DEB-associated toxicities involve redox 
mechanisms, we analyzed DEB- induced SCE frequencies in FA patients and their mothers in 
order to ascertain whether or not that parameter can be used as an adjunct diagnostic tool for at 
least FANCA and FANCD2 complementation groups. In addition, frequencies of SCE induced 
by ionizing radiation are also examined. 
 
MATERIALS AND METHODS 
Study subjects. Subjects included in this study were twelve patients (six boys and six 
girls) with BMF of unknown etiology (non-FA BMF), five Fanconi anemia patients (one boy and 
four girls), and their parents. The patients were aged 8±5 years. Hematological parameters were 
within the range typical of bone marrow failure patients. Clinical diagnosis of FA was supported 
by cellular hypersensitivity to diepoxybutane (AUERBACH, 2003). The FA complementation 
group analysis (Universität Würzburg, Institut für Humangenetik, Germany and Department of 
Genetics Microbiology, Universitat Autonoma de Barcelona, Spain) showed that four patients 
(girls) belong to the complementation group FANCD2, whereas one patient (boy) belongs to the 
complementation group FANCA. The study was approved by the Ethical Committee of the 
Mother and Child Health Care Institute of Serbia, and parents of patients signed an informed 
consent regarding this investigation. A control group was consisted of twelve healthy volunteers 
with normal blood profiles. Peripheral blood samples were obtained in accordance with current 
Health and Ethical Regulations in Serbia.  
Blood cultures. Aliquots of heparinized whole blood (0.5 mL) of patients, their parents 
and controls were added to culture tubes containing 4.5 mL of a PBmax karyotyping medium 
(Invitrogen-Gibco, Paisley, UK). Three lymphocyte cultures from each subject were set up for 
assessment of sister-chromatid exchanges under different conditions of treatment: one culture 
served as a base-line control, the second one was treated with DEB, while the third was set up 
using irradiated peripheral blood samples.  
Sister chromatid exchange analysis. The SCE analysis was performed following the 
addition of 5-bromo-2-deoxyuridine (BrdUrd) (Sigma Chemicals Co., Germany) at a final 
concentration of 15 µg/mL to achieve sister chromatid differentiation. BrdUrd was added one 
hour after culture initiation, and cells were incubated for 72 hours; the last three hours in a 
presence of Colchicine (Sigma Chemicals Co., Germany) at a final concentration of 2.5 µg/mL. 
The cells were harvested and processed through treatments with a hypotonic solution (0.56% 
KCl) and fixative (3:1 methanol:glacial acetic acid). Differential staining of sister chromatids 
was performed by the standard fluorescence-plus-Giemsa technique (PERRY and WOLFF, 
1974). A total of 50 well-spread and complete second-division metaphases per culture were 
scored for SCE using a Ziess-Axioplan2 microscope (Carl Zeiss, Jena, Germany). The frequency 
of SCE per cell was recorded. 
DEB treatment. Lymphocyte cultures were treated with diepoxybutane (Sigma 
Chemicals Co., Germany)  (final concentration 0.1µg/mL) one hour after culture initiation and 
incubated for 72 hours. 
Irradiation. Heparinized whole blood was irradiated using a 60Co γ-ray source. The 
radiation dose employed was 2 Gy, the dose rate was 0.45 Gy/min, the dimensions of the 
radiation field were 20 × 20 cm, and the distance from the radiation source was 74 cm. Aliquots 
of irradiated whole blood (0.5mL) were set up into cultures and incubated for 72 hours. 
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Statistical analysis. A statistical analysis was carried out using statistical software 
package Statistics, version 6 for Microsoft Windows. Student’s t test was used, and the p value < 
0.05 was considered to be significant. 
 
RESULTS 
In this study, we analyzed frequencies of SCE in lymphocytes obtained from FA 
patients, non-FA BMF patients, their mothers, and healthy controls. Individual data of baseline, 
DEB-induced and radiation-induced frequencies of SCE are presented on Tables 1-3. The results 
of the current study showed that no significant difference in spontaneous frequencies of SCE 
between FA patients, non-FA BMF patients and healthy controls was observed (Table 4). The 
similar results were seen when mothers of FA and non-FA BMF patients, and control were 
analyzed.  
 
Table 1. The frequencies of SCE in lymphocytes of FA patients and their mothers. 
FA group Patients Baseline DEB -induced Radiation- induced 
Mothers 
of 
patients 
Baseline DEB -induced 
Radiation- 
induced 
FANCD2 
1 3.33±1.78 4.79±2.24 5.20±2.12 1a 3.83±1.62 3.96±1.65 5.30±2.19 
2 5.29±0.80 6.05±3.22 6.72±3.13 2a 3.71±1.78 5.65±2.06 6.78±1.73 
3 5.14±1.46 6.38±2.93 6.32±2.30 3a 4.00±2.16 6.00±1.97 6.70±1.75 
4 3.71±1.68 6.82± 2.77 6.20±2.80 4a 3.97±2.04 6.57±2.03 6.73±2.06 
FANCA 5 3.52±2.53 7.06±3.26 6.97±3.00 5a 3.78±2.03 5.45±2.34 6.40±2.76 
 
 
 
Table 2. The frequencies of SCE in lymphocytes of non-FA BMF patients and their mothers. 
 
 
non-FA 
BMF 
patients 
Baseline DEB -induced 
Radiation- 
induced 
Mothers 
of 
patients 
Baseline DEB -induced 
Radiation- 
induced 
6 3.80±2.05 6.71±2.37 5.38±3.58 6a 4.83±2.07 5.67±2.29 5.51±1.62 
7 3.87±2.62 7.50±2.72 5.32±2.93 7a 3.36±2.09 4.20±2.35 5.53±2.46 
8 4.06±2.29 3.57±3.10 5.97±2.73 8a 3.80±1.80 4.35±2.36 6.12±1.63 
9 5.06±2.84 3.93±3.67 6.94±3.26 9a 3.93±1.64 4.21±2.68 4.85±1.93 
10 3.70±2.05 3.57±1.78 5.69±2.45 10a 3.57±2.31 4.79±3.77 5.80±2.38 
11 3.91±2.47 3.81±2.45 5.35±2.88 11a 4.67±2.51 5.03±2.42 7.02±2.01 
12 4.97±2.59 3.64±2.18 5.84±2.05 12a 3.97±1.81 5.04±2.41 6.90±1.90 
13 5.54±2.93 4.65±2.46 5.87±2.86 13a 4.57±3.17 4.79±2.44 7.14±2.05 
14 3.13±1.3 4.16±2.27 6.19±2.15 14a 4.39±2.16 5.17±3.33 7.25±2.68 
15 3.41±2.71 1.81±0.88 6.63±2.29 15a 3.54±1.49 2.23±1.16 6.56±2.35 
16 2.79±2.45 2.07±1.79 6.09±2.04 16a 3.77±2.32 1.83±0.94 7.24±1.94 
17 3.30±1.62 2.86±1.90 5.50±2.28 17a 4.27±1.51 2.17±1.37 5.06±1.52 
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Table 3. The frequencies of SCE in lymphocytes of healthy controls. 
 
 
 
Table 4. The baseline, DEB-induced and radiation-induced frequencies of SCE (mean ± S.D) in FA and 
non-FA BMF patients, their mothers, and healthy controls. 
 
*comparison with control, **comparison with non-FA BMF, ns- no significant 
 
 
However, in response to DEB FA patients displayed the highest frequency of SCE, over 
50% higher compared to both non-FA BMF patients and control, and 48% higher than the 
untreated self-control (p < 0.05)  (Figure 1).  
Control subjects Baseline DEB -induced Radiation- induced 
18 4.90±3.07 4.43±1.39 5.29±2.63 
19 3.90±1.56 3.97±1.26 4.67±1.45 
20 3.07±1.37 2.27±1.29 3.97±1.61 
21 4.08±2.72 5.52±3.46 5.45±2.93 
22 4.87±2.06 4.26±2.78 4.85±1.82 
23 5.67±2.28 4.60±1.31 5.95±2.21 
24 6.27±2.54 5.67±3.64 6.67±2.44 
25 4.81±2.27 3.37±1.64 5.55±2.32 
26 3.19±1.31 2.13±1.32 5.95±1.58 
27 5.53±2.08 4.43±1.62 5.90±2.09 
28 4.25±2.12 3.19±1.62 5.53±2.24 
29 5.84±2.33 5.12±2.75 6.80±2.39 
 
Baseline 
frequency 
of SCE 
t test 
Frequency 
of  DEB –
induced SCE 
t test 
Frequency 
of   
radiation- 
induced SCE 
t test 
 
Control 4.70±1.03 - 4.08±1.15 - 5.55±0.80 - 
FA patients 4.20±0.94 
*ns 
**ns 
6.22±0.89 
*p < 0.05 
**p < 0.05 6.28±0.68
 
*ns 
**ns 
Mothers of FA 
patients 3.86±0.12 
*ns 
**ns 
5.53±0.97 
*p < 0.05 
**p < 0.05 6.38±0.62
 
*ns 
**ns 
non-FA BMF 
patients 3.96±0.83 
*ns 4.02±1.66 *ns 5.90±0.51 *ns 
Mothers of  non-
FA BMF patients 4.06±0.48 
*ns 4.12±1.30 *ns 6.25±0.88 *ns 
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The data obtained from FA female carriers showed the similar pattern as they had 
significantly higher DEB-induced frequency of SCE compared to both mothers of non-FA BMF 
patients and control. In the same way, mothers of FA patients displayed 43% higher frequency of 
SCE compared to self-state before DEB treatment (p < 0.05).  
On the other hand, statistical analysis failed to show any significant differences in DEB-induced 
SCE frequencies in non-FA BMF families. The frequency of DEB-induced SCE in healthy 
controls was significantly reduced (p < 0.05) compared to untreated self-control (Figure 1). 
Figure 2 shows metaphases displaying 13 SCE and asymmetrical chromatid exchange in FA 
cells treated with DEB. 
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Figure 1. The frequency of SCE induced by DEB and ionizing radiation (mean ± S.D) in FA and non-FA 
BMF patients, their mothers and controls. 
 
 
                      
                A                                         B     
Figure 2. Representative metaphases analyzed for SCE: (A) SCE at chromosomal termini, (B) incomplete 
asymmetrical exchange with chromatid gap in FANCD2 cell 
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Considering the radiation-induced SCE frequencies, excess values, significantly higher 
than the unirradiated self-controls are noted in all studied groups (Figure 1). However, there 
were no differences in SCE frequencies between patients and control. Comparable results were 
seen when mothers of FA and non-FA BMF patients, and control were analyzed (Table 4). 
The limited number of FANCA patients made it difficult to analyze complementation 
group-related differences in a base-line as well as in induced SCE frequencies. FANCA patient 
displayed slightly reduced baseline frequency of SCE compared to both FANCD2 patients and 
control. The frequencies of SCE induced by DEB and ionizing radiation in FANCA patient were 
modesty increased compared to frequencies observed in FANCD2 patients. 
 
DISCUSSION 
The role of the FANC protein network is both to promote translesion synthesis (TLS) at 
stalled/blocked replication forks and to promote homologous recombination (HR) repair at 
broken replication forks. A deficiency in the latter process could be expected to result in reduced 
spontaneous SCE in FA cells which is not observed (THOMPSON and HINZ, 2009). This finding 
suggests that there is more than one pathway of HR that participates in restarting broken 
replication forks. In agreement with that, in the current study, no differences in spontaneous 
frequencies of SCE between FA patients, non-FA BMF patients and healthy controls were 
observed.  
As mentioned before, studies on induced SCE in FA cells mostly suggest decreased 
SCE frequencies in response to diepoxybutane. However, in our study DEB-induced SCE 
frequencies in FA patients and their mothers were significantly increased compared to both non-
FA BMF families and healthy controls. In control, progression of SCE in response to DEB is 
significantly suppressed, which is probably due to activity of RAD52 that increases the level of 
resistance to the cross-linking agents (PARK, 1995; JOHNSON et al., 1996).  
Diepoxybutane is a highly reactive compound. Upon epoxide hydrolysis, DEB can covalently 
bind to DNA bases. Likewise, DEB generates reactive oxygen species that, in turn, can either 
damage DNA or produce H2O2 (EREXSON and TINDALL, 2000). The fact that DEB induces 
elevated frequency of SCE in FA patients and female carriers shedding new light on the redox-
dependent mechanisms in DEB toxicity, and suggests a direct association of oxidative stress with 
the primary genetic defect in FA, at least for complementation groups FANCA and FANCD2. 
DEB toxicity includes modulation of catalase and MnSOD activities, and glutathione depletion 
(PAGANO and KORKINA, 2000). In addition, DEB-sensitivity has been suggested to be due to the 
lack of glutathione S-transferase (GST) T1 (LANDI et al., 1996), which should be further 
examined in FA patients. It has been reported that hypoxia or antioxidants both correct 
spontaneous as well as DEB-induced chromosomal instability. Moreover, catalase is specifically 
involved in DEB and MMC detoxification hence its defective expression is consistent with FA 
cell sensitivity to these agents  (KORKINA et al., 2000). The inefficient removal of peroxide can 
result in high rates of sister chromatid exchange  (NICOTERA et al., 1989). A recent study from 
our laboratory has shown that FA patients (FANCA and FANCD2) and their mothers display 
decreased catalase activity (PETROVIC et al., 2011), which may account for at least a part of the 
observed outcomes in the current study. In other words, the extensive chromosome aberrations 
often seen in FA cells may be results of increased DNA damage by excessive generation of ROS 
along with compromised DNA damage response processes linked to HR. 
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The finding of increased SCE suggests inability of the cell to repair efficiently 
replication-blocking lesions, which results in the fork collapse and the initiation of HR. In 
addition, defects in single strand break repair (SSBR) also lead to enhanced SCE frequencies, 
trough formation of double strand breaks upon a replication fork collapse at the SSB site, when 
HR than usually uses sister chromatid to facilitate accurate repair. In normal DNA replication, 
SCE occurs upon a natural fork collapse with estimates being 3-4 exchanges per cell per cycle. 
However, Thyagarajan and Campbell (THYAGARAJAN and CAMPBELL, 1997) reported that in FA 
fibroblasts recombination levels are nearly 100-fold higher than that in controls, which 
contribute to the genomic instability and cancer predisposition that characterized Fanconi 
anemia.  
The results of the present study showed that in response to ionizing radiation SCE 
frequencies were significantly increased in all studied groups, but no differences between FA 
patients and non-FA BMF patients were seen. These results suggest that radiation-induced SCE 
frequencies cannot be used as a diagnostic tool for discrimination of FA in the large group of 
BMF patients.   
In conclusion, our data confirm and expand previous findings by showing that SCE 
induced by DEB can be used as an adjunct diagnostic test not only for FA patients, but also for 
female heterozygous carriers, at least for complementation groups FANCA and FANCD2.  
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Izvod 
Fankonijeva anemija (FA) je genetički heterogena, retka bolest, koju karakterišu razvojne 
anomalije, progresivna aplazija kostne srži i sklonost ka oboljevanju od karcinoma. Kliničke 
manifestacije bolesti u odredjenom satrosnom dobu, mogu biti veoma slične aplaziji kostne srži 
drugog porekla. Diferencijalna dijagnostika ove dve kategorije uobičajeno se radi testom 
indukcije hromozomskih aberacija alkilirajućim agensima, tzv. Diepoksibutan (DEB) testom na 
limfocitima periferne krvi in vitro, ali su dragoceni svi drugi testovi koji mogu pomoći u 
postavljanju pravilne dijagnoze.U ovom radu prikazani su rezultati ispitivanja spontane i 
indukovane učestalosti izmena sestrinskih hromatida (SCE) u ćelijama poreklom od FA 
pacijenata, pacijenata obolelih od aplazije kostne srzi, njihovih roditelja, i odgovarajućih 
kontrola.  Rezultati ispitivanja su pokazali da se bazalna učestalost izmena sestrinskih hromatida 
ne razlikuje izmedju tri navedene grupe. Tretman DEB-om, u trajanju od 24h  finalne 
concentracije 0.1µg/ml indukuje dvostruko povećanje učestalosti SCE samo u grupi FA 
pacijenata i njihovih majki. Iznenadjujuće je da se heterozigotni nosioci mutacije u FA genima 
ženskog pola (majke), in vitro, po učestalosti SCE ne razlikuju od homozigotnih nosilaca 
mutacije. Ćelije poreklom od pacijenata sa drugim uzrokom aplazije kostne srži ponašaju se 
slično kontrolnim. Učestalost SCE u in vitro ozračenim uzorcima krvi navedenih grupa, ne 
pokazuje statistički značajnu razliku. Na osnovu dobijenih rezultata može se zaključiti da 
indukovana učestalost SCE alkilirajućim agensima može da bude od značaja kao dodatni test u 
diferencijalnoj dijagnostici FA ćelijkog fenotipa.  
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